May 17, 2020

Study Says an Aspirin Every Other Day Keeps Colon Cancer Away for Women

3 min
Study Says an Aspirin Every Other Day Keeps Colon Cancer Away for Women.jpg
Written by Alyssa Clark Study Says an Aspirin Every Other Day Keeps Colon Cancer Away for Women A twist on the “old school” placebo test, a...

Written by Alyssa Clark

Study Says an Aspirin Every Other Day Keeps Colon Cancer Away for Women

A twist on the “old school” placebo test, a recent 18 year long survey says that women who will take an aspirin every other day will decrease their risk for colon cancer by 42%. Conducted by the Annals of Internal medicine, this study reminds patients that one mindless five minute task could a “saving grace” for personal health— in that case, those are five minutes I’d be gladly willing to give.

Why aspirin? Aspirin helps cells to prevent becoming malignant by preserving the “good cells” composition on the molecular level. The study produced significant results, even only after the first 10 years of testing, showing that women who had been taking the aspirin the longest, were the most protected. This study signifies the need within our own respective daily lives to take those extra five minutes to take care of ourselves, because in the end, those five minutes may save your life.

The study found a direct correlation between a substantial drop in colon cancer in women who had received the placebo to those who were administered aspirin on a every other day basis. Following a group of 34,000 women, the study found those who took aspirin on average 3 times a week to have a 42% less chance of developing colon cancer. With those numbers being almost half of all patients able to possibly become diagnosed with colon cancer, there is no better time than the present to start investing in your most important resource: your health!

Researchers wanted to proactively remind part-takers of the study, and those adopting it in their own personal lives, not too go overboard with taking the aspirin. The regimen calls for every other day consumption, and it’s important to stick to what the doctors order in this case. Aspirin can still have serious side effects such as stomach bleeding and ulcers, so doctors want to ensure that there are continuously patients safe and healthy. The every other day method provides more than enough protection, and no added dosages are necessary.

As to not leave men out of this exciting discovery, the data showed that men could possibly gain protection form colon cancer as well by adding in this routine of taking aspirin every other day to their daily regimen. Across the board, whether your family has a clean bill of health with colon cancer or not, aspirin can help alleviate your potential risk for colon cancer whether your male or female.

If you decide to be proactive about your colon health and incorporate the aspirin regimen into your daily diet, be sure to not ignore your standard health procedures as well. Make appointments to see your general practitioner, go to them and stayed informed. Do not rely solely on aspirin to take care of you; your doctor is there for a reason.


About the Author

Alyssa Clark is the Editor of Healthcare Global

Share article

May 13, 2021

Birdie aims to reinvent elderly care with tech

3 min
We take a look at homecare software startup Birdie, who are aiming to transform elderly care in the UK

British startup Birdie has announced it has raised £8.2 million to invest in innovation and scale up the business. 

The company's announcement is timely as it follows the criticism of the UK government over their lack of a plan for social care, despite acknowledging the sector is in crisis - around a quarter of the UK's home care providers are on the brink of bankruptcy due to a lack of funds and staffing. 

Birdie was born with a mission to  "radically improve the lives of millions of older adults", by using app-based solutions, IoT and machine learning to put preventative care at the forefront.  The company was founded by Max Parmentier,  after experiencing his own frustrations with the care system - his grandfather struggled with the impact of life in a care home, but lacked any other option. 

In 2017 Parmentier partnered with venture builder Kamet Ventures to  set up Birdie, in a bid to fix this problem. Since then, Birdie has partnered with almost 500 providers across the UK, and supports more than 20,000 older people every week. In the past 12 months alone the number of people Birdie supports has got six times greater. 

Birdie’s solution is an app to help care providers deliver more coordinated, personalised and preventative care, by giving them access to digital assessments, medication scheduling and planning tools. By using digital tools to take care of admin, staff have more time to spend with their care recipients. 

The new investment will be used to fund Birdie’s next phase of growth in the UK, as the company scales to meet the rapidly growing demand of the aging population. The company will also invest in product innovation, creating new features to address customer requests.

In addition, Birdie is piloting new care models, including partnering with the NHS to identify COVID-19 symptoms, building predictive pharmacy models with AI, and helping health authorities to detect early warning signs of patients’ health risks.

Internally, Birdie is committed to having a progressive company ethos. All salaries are transparent, and staff work asynchronously to maximise flexibility and equity. Staff members also volunteer in their local community during office hours, and the company offsets all its emissions.

These efforts have led to numerous awards, including having the best SME culture in the UK, an Honorable Mention in the Health category of Fast Company’s 2021 World Changing Ideas Awards, and innovation in care at the LangBuisson awards. 

“We believe the future of care for older people should be helping them to live at home for as long as possible through the delivery of personalised and preventative care" Parmentier said. 

"Birdie is already the partner of choice for caregivers up and down the UK, and this new funding will help us rapidly increase the number we partner with and what we can offer them - meaning more people benefiting from more affordable, quality care. We’re proud of our mission and the values we embody to pursue it.” 

Share article